Σχέσεις με τους ΕπενδυτέςΟικονομικά Στοιχεία
  1. Home
  2. Medical Imaging
  3. Molecular Imaging
SNMMI

Molecular Imaging

product image biograph vision

Answering to clinical needs in oncology, neurology, cardiology, and radiology, Siemens Healthineers Molecular Imaging systems provide PET/CT, SPECT, and hybrid SPECT scanner (SPECT/CT) solutions to help clinicians diagnose, treat, and monitor diseases more confidently. 

Highlights

Scanners

Reading Software

Nuclear Medicine News & Stories

By Claudette Lew

Total-body multiparametric PET/CT allows clinician researchers to see further

 2025-01-14

Clinician researchers at Aarhus University Hospital in Denmark were early adopters of total-body multiparametric PET/CT imaging and are now working with Biograph Vision Quadra™. The team is focused on identifying the critical applications where the precise quantification of tracer dynamics can yield the most significant clinical benefits.

News
By Sameh Fahmy

Theranostics for neuroendocrine tumors: A patient’s experience

 2024-12-02

After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred for theranostics treatment. 

News
By Sameh Fahmy

Theranostics center of excellence: transforming oncology care

 2024-12-01
Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.
News
By Catherine Marcic Joyce

Highlights from the EANM 2024 Annual Congress

 2024-11-15

The European Association of Nuclear Medicine’s 37th Annual Meeting took place October 19–23, 2024, in Hamburg, Germany.

News

By Claudette Lew

PET/CT biomarkers enable clinicians to advance Alzheimer’s disease care

 2024-09-19
With the latest molecular imaging tools and biomarkers to enhance diagnostic accuracy and enable disease-modifying treatments, clinicians are paving the way for Alzheimer's disease care.
News
¹ Fastest measured value on a single system. Based on competitive literature at time of publication. Data on file.